Prevalence of celiac disease in low and high risk population in Asia–Pacific region: a systematic review and meta-analysis

Abstract This systematic review and meta-analysis study was conducted to estimate the pooled prevalence of CD in low and high risk groups in this region. Following keywords were searched in the Medline, PubMed, Scopus, Web of Science and Cochrane database according to the MeSH terms; celiac disease,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sara Ashtari, Hadis Najafimehr, Mohamad Amin Pourhoseingholi, Kamran Rostami, Hamid Asadzadeh-Aghdaei, Mohammad Rostami-Nejad, Mostafa Rezaei Tavirani, Meysam Olfatifar, Govind K. Makharia, Mohammad Reza Zali
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/83cd2d4b8eac4f91b07dcb04c0af8d77
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:83cd2d4b8eac4f91b07dcb04c0af8d77
record_format dspace
spelling oai:doaj.org-article:83cd2d4b8eac4f91b07dcb04c0af8d772021-12-02T10:48:31ZPrevalence of celiac disease in low and high risk population in Asia–Pacific region: a systematic review and meta-analysis10.1038/s41598-021-82023-82045-2322https://doaj.org/article/83cd2d4b8eac4f91b07dcb04c0af8d772021-01-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-82023-8https://doaj.org/toc/2045-2322Abstract This systematic review and meta-analysis study was conducted to estimate the pooled prevalence of CD in low and high risk groups in this region. Following keywords were searched in the Medline, PubMed, Scopus, Web of Science and Cochrane database according to the MeSH terms; celiac disease, prevalence, high risk population and Asian-Pacific region. Prevalence studies published from January 1991 to March 2018 were selected. Prevalence of CD with 95% confidence interval (CI) was calculated using STATA software, version 14. The pooled sero-prevalence of CD among low risk group in Asia–Pacific region was 1.2% (95% CI 0.8–1.7%) in 96,099 individuals based on positive anti-tissue transglutaminase (anti-t-TG Ab) and/or anti-endomysial antibodies (EMA). The pooled prevalence of biopsy proven CD in Asia–Pacific among high and low risk groups was 4.3% (95% CI 3.3–5.5%) and 0.61% (95% CI 0.4–0.8%) in 10,719 and 70,344 subjects, respectively. In addition, the pooled sero-prevalence and prevalence of CD in general population was significantly higher in children compared with adults and it was significantly greater in female vs. male (P < 0.05). Our results suggest high risk individuals of CD are key group that should be specifically targeted for prevention and control measures, and screening may prove to have an optimal cost–benefit ratio.Sara AshtariHadis NajafimehrMohamad Amin PourhoseingholiKamran RostamiHamid Asadzadeh-AghdaeiMohammad Rostami-NejadMostafa Rezaei TaviraniMeysam OlfatifarGovind K. MakhariaMohammad Reza ZaliNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-13 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Sara Ashtari
Hadis Najafimehr
Mohamad Amin Pourhoseingholi
Kamran Rostami
Hamid Asadzadeh-Aghdaei
Mohammad Rostami-Nejad
Mostafa Rezaei Tavirani
Meysam Olfatifar
Govind K. Makharia
Mohammad Reza Zali
Prevalence of celiac disease in low and high risk population in Asia–Pacific region: a systematic review and meta-analysis
description Abstract This systematic review and meta-analysis study was conducted to estimate the pooled prevalence of CD in low and high risk groups in this region. Following keywords were searched in the Medline, PubMed, Scopus, Web of Science and Cochrane database according to the MeSH terms; celiac disease, prevalence, high risk population and Asian-Pacific region. Prevalence studies published from January 1991 to March 2018 were selected. Prevalence of CD with 95% confidence interval (CI) was calculated using STATA software, version 14. The pooled sero-prevalence of CD among low risk group in Asia–Pacific region was 1.2% (95% CI 0.8–1.7%) in 96,099 individuals based on positive anti-tissue transglutaminase (anti-t-TG Ab) and/or anti-endomysial antibodies (EMA). The pooled prevalence of biopsy proven CD in Asia–Pacific among high and low risk groups was 4.3% (95% CI 3.3–5.5%) and 0.61% (95% CI 0.4–0.8%) in 10,719 and 70,344 subjects, respectively. In addition, the pooled sero-prevalence and prevalence of CD in general population was significantly higher in children compared with adults and it was significantly greater in female vs. male (P < 0.05). Our results suggest high risk individuals of CD are key group that should be specifically targeted for prevention and control measures, and screening may prove to have an optimal cost–benefit ratio.
format article
author Sara Ashtari
Hadis Najafimehr
Mohamad Amin Pourhoseingholi
Kamran Rostami
Hamid Asadzadeh-Aghdaei
Mohammad Rostami-Nejad
Mostafa Rezaei Tavirani
Meysam Olfatifar
Govind K. Makharia
Mohammad Reza Zali
author_facet Sara Ashtari
Hadis Najafimehr
Mohamad Amin Pourhoseingholi
Kamran Rostami
Hamid Asadzadeh-Aghdaei
Mohammad Rostami-Nejad
Mostafa Rezaei Tavirani
Meysam Olfatifar
Govind K. Makharia
Mohammad Reza Zali
author_sort Sara Ashtari
title Prevalence of celiac disease in low and high risk population in Asia–Pacific region: a systematic review and meta-analysis
title_short Prevalence of celiac disease in low and high risk population in Asia–Pacific region: a systematic review and meta-analysis
title_full Prevalence of celiac disease in low and high risk population in Asia–Pacific region: a systematic review and meta-analysis
title_fullStr Prevalence of celiac disease in low and high risk population in Asia–Pacific region: a systematic review and meta-analysis
title_full_unstemmed Prevalence of celiac disease in low and high risk population in Asia–Pacific region: a systematic review and meta-analysis
title_sort prevalence of celiac disease in low and high risk population in asia–pacific region: a systematic review and meta-analysis
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/83cd2d4b8eac4f91b07dcb04c0af8d77
work_keys_str_mv AT saraashtari prevalenceofceliacdiseaseinlowandhighriskpopulationinasiapacificregionasystematicreviewandmetaanalysis
AT hadisnajafimehr prevalenceofceliacdiseaseinlowandhighriskpopulationinasiapacificregionasystematicreviewandmetaanalysis
AT mohamadaminpourhoseingholi prevalenceofceliacdiseaseinlowandhighriskpopulationinasiapacificregionasystematicreviewandmetaanalysis
AT kamranrostami prevalenceofceliacdiseaseinlowandhighriskpopulationinasiapacificregionasystematicreviewandmetaanalysis
AT hamidasadzadehaghdaei prevalenceofceliacdiseaseinlowandhighriskpopulationinasiapacificregionasystematicreviewandmetaanalysis
AT mohammadrostaminejad prevalenceofceliacdiseaseinlowandhighriskpopulationinasiapacificregionasystematicreviewandmetaanalysis
AT mostafarezaeitavirani prevalenceofceliacdiseaseinlowandhighriskpopulationinasiapacificregionasystematicreviewandmetaanalysis
AT meysamolfatifar prevalenceofceliacdiseaseinlowandhighriskpopulationinasiapacificregionasystematicreviewandmetaanalysis
AT govindkmakharia prevalenceofceliacdiseaseinlowandhighriskpopulationinasiapacificregionasystematicreviewandmetaanalysis
AT mohammadrezazali prevalenceofceliacdiseaseinlowandhighriskpopulationinasiapacificregionasystematicreviewandmetaanalysis
_version_ 1718396658764480512